Stock Earnings

Question 1

What are Serina Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Serina Therapeutics Inc has a total asset of $6, Net loss of $-11

Question 2

What are the key financial ratios for SER?

Accepted Answer

Serina Therapeutics Inc's Current ratio is 1, has a Net margin is 0, sales per share of $0.

Question 3

How is Serina Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Serina Therapeutics Inc largest revenue segment is Grant Revenues, at a revenue of 77,000 in the most earnings release.For geography, United States is the primary market for Serina Therapeutics Inc, at a revenue of 90,000.

Question 4

Is Serina Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Serina Therapeutics Inc has a net loss of $-11

Question 5

Does Serina Therapeutics Inc have any liabilities?

Accepted Answer

yes, Serina Therapeutics Inc has liability of 6

Question 6

How many outstanding shares for Serina Therapeutics Inc?

Accepted Answer

Serina Therapeutics Inc has a total outstanding shares of 9.42

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	-100%
Cost of Revenue	--	--	0	0	0	0
Gross Profit	--	--	0	0	0	0
Selling, General & Admin	8	9	9	5	6	6
Research & Development	8	7	0	0	1	3
Operating Expenses	16	17	10	7	8	10
Other Non Operating Income (Expenses)	6	13	0	0	0	0
Pretax Income	-9	-11	-14	-10	-8	-10
Income Tax Expense	--	--	--	--	0	0
Net Income	-9	-11	-14	-10	-8	-10
Net Income Growth	-50%	-21%	40%	25%	-20%	-17%
Shares Outstanding (Diluted)	10	7.35	1.07	37.95	37.89	37.67
Shares Change (YoY)	18%	582%	-97%	0%	1%	1%
EPS (Diluted)	-0.98	-1.51	-13.71	-0.28	-0.23	-0.27
EPS Growth	-55%	-89%	4,800%	22%	-15%	-18%
Free Cash Flow	-15	-17	-7	-5	-7	-7
Free Cash Flow Per Share	-1.49	-2.31	-6.48	-0.13	-0.18	-0.18
Gross Margin	--	--	0%	0%	0%	0%
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-16	-17	-9	-6	-8	-10
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-16	-17	-9	-6	-8	-10
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	0%	0%

Serina Therapeutics Inc (SER) Price

SER Stock Price Chart

SER Income

Follow-Up Questions